Scientific publications

Journal of Ethnopharmacology, 2026

OLink proteomic biomarker to predict clinical efficacy of Macaranga sinensis Müll.Arg: A nested case-control study

Chen G., Zhou S., Chen Y. et al.

Journal of Cachexia, Sarcopenia and Muscle, 2026

Integrated Proteomic and Metabolomic Profiling for Developing Novel Plasma‐Based Diagnostic Models of Sarcopenia

Xu D., Jin H., Yang J. et al.

Neurology Neuroimmunology & Neuroinflammation, 2026

Nasal Foralumab for the Treatment of Progression Independent of Relapses in Patients With Nonactive Secondary Progressive Multiple Sclerosis

Chitnis T., Singhal T., Zurawski J. et al.

Frontiers in Immunology, 2026

Circulating fibroblasts and neutrophils co-expressing CDH11+ and chemokine receptors in rheumatoid and psoriatic arthritis: a shared mechanism of ‘arthritis spreading’?

Kyriakidi M., Vetsika E., Fragoulis G. et al.

Nature Medicine, 2026

Genotype-stratified adjunctive dexamethasone for tuberculous meningitis in HIV-negative adults: a randomized controlled phase 3 trial

Donovan J., Duc Bang N., Dong H. et al.

Journal of Pediatric Gastroenterology and Nutrition, 2026

Beyond eosinophils: A proteomic dissection of remodeling and inflammation in suspected eosinophilic esophagitis

Eindor‐Abarbanel A., Moss‐ Ophir N., Agajany N. et al.

Blood Neoplasia, 2026

Proteome-wide Mendelian Randomisation Identifies Protein Associations and Therapeutic Targets for B-cell Malignancy

Went M., Mills C., Sud A. et al.

Annals of the Rheumatic Diseases, 2026

Type I interferon endotypes drive divergent clinical trajectories in childhood-onset SLE uncovered through a novel systems immunology approach

Cross H., Peng J., McDonnell T. et al.

Cytotherapy, 2026

Chronic graft-versus-host disease suppressing CD56brightPerforinneg regulatory-like NK cells inhibit CD4+ T cells via PD-1, LAG-3, and TRAIL

Lauener M., Normand M., Ngo T. et al.

Metabolism, 2026

Multi-omics profiling reveals CKM syndrome severity as a gradient risk factor for cancer: A prospective cohort study

Huang Y., Zhang Y., Zhang Y. et al.

mBio, 2026

Lineage-matched Oropouche virus mRNA-LNP vaccines confer complete, cross-protective immunity in mice

Yamada Y., Cha I., Kang S. et al.

FEBS Open Bio, 2026

Microglial dynamics and ferroptosis induction in human iPSC ‐derived neuron–astrocyte–microglia tri‐cultures

Li H., Ohmiya H., Sakamoto S. et al.

Lifestyle Genomics, 2026

Inflammatory proteins mediate the causal association between sleep traits and breast cancer: a Mendelian randomization study

Zhou J., Mao L.

Carcinogenesis, 2026

Plasma proteomic profiling identified prognostic indicators with therapeutic potential for colorectal cancer

Xie X., Zhou J., Wu Q. et al.

Cell Metabolism, 2026

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night

Marjot T., Smith K., Westcott F. et al.

HemaSphere, 2026

Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy

Vänttinen I., Saad J., Ruokoranta T. et al.

Aging Cell, 2026

The Secretome of Human Trophoblast Stem Cells Attenuates Senescence‐Associated Traits

Abdelmohsen K., Martindale J., Rossi M. et al.

Advanced Biology, 2026

Proteomic Signatures Over Age Reveal Significant Changes From Infancy Till Late Adulthood

Delemarre E., Smits H., van Baarle D. et al.

Environment International, 2026

Molecular basis for the early life sensitization of the brain to ultrafine carbonaceous particles: a study of the brain proteome, telomeres, and epigenetic modelling

Vanbrabant K., Rasking L., Alfano R. et al.

Nature Medicine, 2026

BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

Fedak R., Ruggerie R., Shan Y. et al.